Medical Breakthroughs in 2024: Alzheimer’s, schizophrenia, COPD, MASH see pathbreaking treatments

Data Compilation
#PharmaFlow

Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

Stock Recap
#PipelineProspector

Trandolapril

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

15 API Suppliers, 8 USDMF, 6 CEP/COS, 3 JDMF, 3 EU WC, 4 NDC API, 6 Listed Suppliers, $ API Reference Price

INTERMEDIATES

3 Intermediates Suppliers

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

106 FDF Dossiers, 33 FDA Orange Book, 8 Europe, 29 Canada, 24 Australia, 8 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 5 SPI Pharma, 2 Seqens, 4 DKSH, 2 Jai Radhe Sales, 5 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 13 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 6 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 16 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

74 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 33 Direct Compression, 29 Controlled & Modified Release, 24 Disintegrants & Superdisintegrants, 20 Granulation, 20 Thickeners and Stabilizers, 20 Lubricants & Glidants, 18 Co-Processed Excipients, 13 Solubilizers, 9 Film Formers & Plasticizers, 8 Topical, 8 Chewable & Orodispersible Aids, 7 Taste Masking, 6 Parenteral, 5 Empty Capsules, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Emulsifying Agents, 4 Rheology Modifiers, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 NEWS #PharmaBuzz

3 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 17 Finished Drug Prices

MARKET PLACE

2 APIs

2 APIs

PATENTS & EXCLUSIVITIES

7 Health Canada Patents

7 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 6 Others

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
26/09/2024	Chunghwa Chemical Synthesis & Biotech	Taiwan	Chunghwa Chemical Synthesis & Biotech Co. , Ltd.	225MF10083	Trandolapril	2013-04-23	2020-03-23	No. 1, Tung-Hsing St. , Shu-Lin, New Taipei City 23850, Taiwan
26/09/2024	Chunghwa Chemical Synthesis & Biotech	Taiwan	CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO. , LTD.	218MF10666	Trandolapril	2006-07-24	2006-07-24	1, Tung-Hsing, Street, Shu-Lin 238, Taipei Hsien, Taiwan, Republic of China

Trandolapril

Trandolapril

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

15 API Suppliers

8 USDMF

6 CEP/COS

3 JDMF

3 EU WC

4 NDC API

6 Listed Suppliers

$ API Reference Price

INTERMEDIATES

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

106 FDF Dossiers

33 FDA Orange Book

8 Europe

29 Canada

24 Australia

8 South Africa

4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

5 SPI Pharma

2 Seqens

4 DKSH

2 Jai Radhe Sales

5 Faran Shimi Pharmaceutical

4 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

13 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 ACG Worldwide

3 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

17 BASF

1 Clariant

10 Corel Pharma Chem

6 DFE Pharma

1 Finar

7 Gangwal Chemicals

6 Ideal Cures Pvt Ltd

3 Ingredion Pharma Solutions

36 Kerry

3 Kima Chemical

6 Lonza Capsugel

12 Microlex e.U

1 NEWEDGE Overseas

2 Nomisma Healthcare

2 Novo Excipients

3 Pharmatrans-Sanaq

5 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

16 Roquette

7 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

11 Sigachi Industries

2 The Dow Chemical Company

2 Ulanqab Kema New Material

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

74 Fillers, Diluents & Binders

47 Coating Systems & Additives

33 Direct Compression

29 Controlled & Modified Release

24 Disintegrants & Superdisintegrants

20 Granulation

TABLET;ORAL - 1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons